SCHEMBL7744597

SCHEMBL7744597

O=C(NC1(c2ccccc2)CCN(OS(=O)(=O)c2ccccc2)CC1)N1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.44
HSD11B1 P28845 2/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
USP2 O75604 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
GAA P10253 2/20 0.37
NPC1 O15118 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALPG P10696 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HTT P42858 1/20 0.37
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8368905 0.92 KMT2A (0.43) POLBALDH1A1KMT2AMEN1HPGD
SCHEMBL7683426 0.84 POLB (0.46) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7749117 0.83 ALDH1A1 (0.51) POLBALDH1A1KMT2AMEN1SMN1; SMN2
Water SCHEMBL7749373 0.82 ALDH1A1 (0.50) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7678500 0.82 POLB (0.47) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7685568 0.79 ALDH1A1 (0.50) POLBHSD11B1ALDH1A1KMT2AMEN1
SCHEMBL7744607 0.78 POLB (0.57) POLBALDH1A1KMT2AMEN1HPGD
SCHEMBL7744594 0.78 CYP1A2 (0.43) POLBHSD11B1ALDH1A1KMT2AMEN1
SCHEMBL6447443 0.77 POLB (0.45) POLBALDH1A1KMT2AMEN1LMNA
SCHEMBL7750046 0.77 POLB (0.45) POLBALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242637-B1 USED IN TREATMENT INVOLVING THE TACHYKININ SYSTEM, SUCH AS PAIN, ALLERGY AND INFLAMMATION, CIRCULATORY, GASTROINTESTINAL, NEUROLOGICAL, AND NEUROPSYCHIATRIC DISORDERS SANOFI-SYNTHELABO (FR) 2001-06-05 US disclosed
US-6011154-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 2000-01-04 US disclosed
US-5977359-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 1999-11-02 US disclosed
US-5869663-A INTERMEDIATES FOR NEUROKININ RECEPTOR ANTAGONISTS SANOFI (FR) 1999-02-09 US disclosed
US-5780466-A DISORDERS ASSOCIATED WITH EXCESS TACHYKININS AND ALL NEUROKININ-DEPENDENT DISORDERS; ANALGESICS; RESPIRATORY, GASTROINTESTINAL, UROGENTIAL, IMMUNE, CARDIOVASCULAR AND CNS DISORDERS SANOFI (FR) 1998-07-14 US disclosed
US-5641777-A NEUROKININ RECEPTOR ANTAGONIST SANOFI (FR) 1997-06-24 US disclosed